Detection of Herba Aristolochia Mollissemae in a patient with unexplained nephropathy

American Journal of Kidney Diseases

Volumn 45, Issue 2, 2005, Pages 407-410

  Lo, Stanley H ^a   Wong, Kin Shing ^b   Arlt, Volker M ^b   Phillips, David H ^b   Lai, Chi Kong ^b   Poon, Wing Tat ^b   Chan, Ching Kit ^b   Mo, Ka Leung ^b   Chan, Kwok Wah ^b   Chan, Albert ^b  

^a PAMELA YOUDE NETHERSOLE EASTERN HOSPITAL   (Hong Kong)

^b NONE

Author keywords

Aristolochic acid associated nephropathy (AAN); Herba Aristolochia Mollissemae; Transitional cell carcinoma

Indexed keywords

ARISTOLOCHIC ACID; DNA; MESALAZINE; PHOSPHORUS 32;

ADULT; ARISTOLOCHIA; ARTICLE; CASE REPORT; CLINICAL FEATURE; COLON CARCINOMA; CROHN DISEASE; DNA ADDUCT; DRUG DETERMINATION; DRUG MONITORING; DRUG WITHDRAWAL; ELECTROSPRAY MASS SPECTROMETRY; HEMODIALYSIS; HERBAL MEDICINE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTERSTITIAL NEPHRITIS; KIDNEY BIOPSY; KIDNEY DISEASE; MALE; NEPHROTOXICITY; TANDEM MASS SPECTROMETRY; TRANSITIONAL CELL CARCINOMA;

EID: 20144364600     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2004.09.019     Document Type: Article

References (14)

1. J.L. Nortier, M.C. Martinez, H.H. Schmeiser Urothelial carcinoma associated with the use of a Chinese herb (Aristolochic Fangchi) N Engl J Med 342 2000 1686 1692
2. C.K. Lai, T. Lee, K.M. Au Uniform solid phase extraction procedures for toxicological screening of drugs in serum and urine by HPLC with DAD Clin Chem 43 1997 312 325
3. G.M. Lord, M. Hollstein, V.M. Arlt DNA adducts and P53 mutations in a patient with aristolochic acid-associated nephropathy Am J Kidney Dis 43 2004 e11 e27
4. Lewis CJ, Alpert S: Letter to Health Care Professionals on FDA concerned about botanical products, including dietary supplements, containing aristolochic acid. US Food and Drug Administration, Centre for Food Safety and Applied Nutrition, Office of nutritional Product, Labelling and Dietary Supplements, May 31, 2000
5. S.H.K. Lo, K.L. Mo, K.S. Wong Aristolochic acid nephropathy complicating a patient with focal segmental glomerulosclerosis Nephrol Dial Transplant 19 2004 1913 1915
6. M.C. Martinez, J.L. Nortier, J.L. Vanherweghem Progression rate of Chinese herb nephropathy Impact of Aristolochia fangchi ingested dose Nephrol Dial Transplant 17 2002 408 412
7. M.J. World, P.E. Stevens, M.A. Ashton, D.J. Rainford Mesalazine- associated interstitial nephritis Nephrol Dial Transplant 11 1996 614 621
8. J. Popoola, A.F. Muller, L. Pollock, P. O'Donnell, P. Carmichael, P. Stevens Late onset interstitial nephritis associated with mesalazine treatment BMJ 317 1998 795 797
9. M.E. De Broe, J.C. Stolear, E.J. Nouwen, M.M. Elseviers 5-Aminosalicylic acid (5-ASA) and chronic tubulointerstitial nephritis in patient with chronic inflammatory bowel disease Is there a link? Nephrol Dial Transplant 12 1997 1839 1841
10. J.L. Vanherweghem, D. Abramowicz, C. Tielemans, M. Depierreux Effects of steroids on the progression of renal failure in chronic interstitial renal fibrosis A pilot study in Chinese herbs nephropathy Am J Kidney Dis 27 1996 209 215
11. W. Chen, Y. Chen, A. Li The clinical and pathological manifestations of aristolochic acid nephropathy-the report of 58 cases Zhonghua Yi Xue Za Zhi 81 2001 1101 1105
12. F.D. Debelle, J. Nortier, E. Prez Aristolochic acids induce chronic renal failure with interstitial fibrosis in salt depleted rats J Am Soc Nephrol 13 2002 431 436
13. S.L. Gold, H.T. Slone Aristolochic acid, an herbal carcinogen, sold on the web after FDA alert N Engl J Med 349 2003 1576 1577
14. G. Gillerot, M. Jadoul, V.M. Arlt Aristolochic acid nephropathy in a Chinese patient Time to abandon the term "Chinese herbs nephropathy"? Am J Kidney Dis 38 2001 E26